{
    "N/R/U": null,
    "Applicant": "GlaxoSmithKline Biologicals",
    "BLA Number": "125363",
    "Proprietary Name": "MENHIBRIX",
    "Proper Name": "Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine",
    "BLA Type": "351(a)",
    "Strength": " 0.5ML",
    "Dosage Form": "Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "June 14, 2012",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": " ",
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1617",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}